financetom
Business
financetom
/
Business
/
South Korea watchdog questions purpose of Hanwha Aerospace's $2.5 billion share issue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
South Korea watchdog questions purpose of Hanwha Aerospace's $2.5 billion share issue
Mar 31, 2025 10:32 PM

SEOUL (Reuters) -South Korea's financial market watchdog said on Tuesday that Hanwha Aerospace needed to better explain how a proposed 3.6 trillion won ($2.46 billion) equity raising fits with a broader plan to restructure the company.

The Financial Supervisory Service (FSS) last week blocked the defence company's controversial capital raising plans on the grounds its filing lacked information needed for shareholders to make rational investment decisions, and ordered it to submit a revised filing.

"The ownership restructuring of affiliates and its relevance to the share issue plan, as well as the impact of the restructuring on the firm should be sufficiently noted," FSS Senior Deputy Governor Hahm Yong-il told a briefing.

On March 21, a day after the plan was announced, shares in Hanwha Aerospace posted their worst session since early November 2016, sinking 13%, as analysts raised questions over the intent and need for raising capital.

Hanwha Group, South Korea's seventh-largest conglomerate, announced on Monday that Chairman Kim Seung Youn was giving an 11.32% stake in Hanwha Aerospace's parent, Hanwha Corp, to his sons as part of a succession process.

Hanwha Aeropsace said on Tuesday its executives, including one of Kim's sons, purchased about 9 billion won worth of shares in the company to show their will to raise shareholder value.

The controversy over Hanwha's share issue plan was the latest in a series of large capital-raising plans, including ones by battery maker Samsung SDI and Korea Zinc, that were met by investor criticism amid South Korea's broader push for corporate governance reforms.

Shares in Hanwha Aerospace jumped 7.5%, while the benchmark KOSPI stock index was up 1.8% as of 0445 GMT.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cargojet Q1 Adjusted Profit Jumps 85%, Revenue Stagnant
Cargojet Q1 Adjusted Profit Jumps 85%, Revenue Stagnant
Apr 29, 2024
08:00 AM EDT, 04/29/2024 (MT Newswires) -- Cargojet ( CGJTF ) , a provider of air cargo services to all major cities across North America, on Monday reported first-quarter adjusted earnings of $31 million, or $1.86 per share, up 84.5% from $16.8 million, or $0.97 per share, a year earlier. Analysts polled by Capital IQ expected $0.62. Revenue for the...
BRIEF-Viking Holdings Ltd Sees Us IPO Of Up To 53 Million Ordinary Shares-SEC Filing
BRIEF-Viking Holdings Ltd Sees Us IPO Of Up To 53 Million Ordinary Shares-SEC Filing
Apr 29, 2024
April 29 (Reuters) - Viking Holdings Ltd: * VIKING HOLDINGS LTD: SEES US IPO OF UP TO 53 MILLION ORDINARY SHARES-SEC FILING * VIKING HOLDINGS LTD: CO OFFERING 11 MILLION ORDINARY SHARES & SELLING SHAREHOLDERS OFFERING 42 MILLION ORDINARY SHARES Further company coverage: ([email protected]) ...
Domino's Pizza Serves Up A Tasty Q1 Surprise, Setting The Table For A Profitable Year
Domino's Pizza Serves Up A Tasty Q1 Surprise, Setting The Table For A Profitable Year
Apr 29, 2024
Domino’s Pizza Inc shares are trading higher after the company reported first-quarter FY24 sales growth of 6% year-on-year to $1.085 billion, beating the analyst consensus estimate of $1.079 billion. The revenue increase was primarily due to higher supply chain revenues and U.S. franchise royalties and fees, as well as higher U.S. Company-owned store revenues.  The growth in supply chain revenues was attributable to higher order volumes,...
Japan's Ono to buy US drugmaker Deciphera for $2.4 bln
Japan's Ono to buy US drugmaker Deciphera for $2.4 bln
Apr 29, 2024
April 29 (Reuters) - Deciphera Pharmaceuticals ( DCPH ) said on Monday Japan's Ono Pharmaceutical Co ( OPHLF ) will acquire the cancer drugmaker for $2.4 billion to expand its oncology portfolio and presence in the United States and Europe. Ono Pharma has offered $25.60 per share in cash, a premium of 74.7% to U.S.-based Deciphera's last closing price of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved